Evidence map›Paper›PMID 32509592›Full record

ArticleFrontiers in cellular and infection microbiology2020

Evaluation of Molecular Epidemiology, Clinical Characteristics, Antifungal Susceptibility Profiles, and Molecular Mechanisms of Antifungal Resistance of Iranian

Amir Arastehfar, Farnaz Daneshnia, Mohammad Javad Najafzadeh, Ferry Hagen, Shahram Mahmoudi, Mohammadreza Salehi, Hossein Zarrinfar, Zahra Namvar, Zahra Zareshahrabadi, Sadegh Khodavaisy and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Antimicrobial agents and chemotherapy · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Comprehensive analysis of the mechanisms conferring resistance to phenamacril in theFrontiers in cellular and infection microbiology · 2025
    Review
  10. Influence of Filler Content and Polishing onThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Article
  11. Inhibitory effect ofIranian journal of microbiology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Antifungal activity of FeScientific reports · 2024
    Article
  16. Antifungal Drug Susceptibility Profile ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2024
    Article
  17. Antifungal Resistance and Genotyping of ClinicalJournal of fungi (Basel, Switzerland) · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 5 countries.

Amir ArastehfarYeast Biodiversity Department, Westerdijk Fungal Biodiversity Institute, Utrecht, Netherlands.
Farnaz DaneshniaYeast Biodiversity Department, Westerdijk Fungal Biodiversity Institute, Utrecht, Netherlands.
Mohammad Javad NajafzadehDepartment of Parasitology and Mycology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Ferry HagenYeast Biodiversity Department, Westerdijk Fungal Biodiversity Institute, Utrecht, Netherlands.
Shahram MahmoudiDepartment of Medical Parasitology and Mycology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mohammadreza SalehiDepartment of Infectious Diseases and Tropical Medicine, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Hossein ZarrinfarAllergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Zahra NamvarDepartment of Microbiology, School of Biological Sciences, Islamic Azad University, Tehran, Iran.
Zahra ZareshahrabadiBasic Sciences in Infectious Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Sadegh KhodavaisyDepartment of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Kamiar ZomorodianBasic Sciences in Infectious Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Weihua PanMedical Mycology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.
Bart TheelenYeast Biodiversity Department, Westerdijk Fungal Biodiversity Institute, Utrecht, Netherlands.
Markus KostrzewaBruker Daltonik GmbH, Bremen, Germany.
Teun BoekhoutYeast Biodiversity Department, Westerdijk Fungal Biodiversity Institute, Utrecht, Netherlands.
Cornelia Lass-FlörlDivision of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
Westerdijk Fungal Biodiversity Institute · NLMashhad University of Medical Sciences · IRShiraz University of Medical Sciences · IRTehran University of Medical Sciences · IRBruker (Germany) · DEInnsbruck Medical University · ATIran University of Medical Sciences · IRIslamic Azad University, Tehran · IRShanghai Changzheng Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clonal expansion of fluconazole resistant (FLZ-R)

Indexed as

Antifungal AgentsCandida parapsilosisAmplified Fragment Length Polymorphism AnalysisDrug Resistance, FungalHumansIranMicrobial Sensitivity TestsMolecular EpidemiologyAntifungal AgentsAFLP genotypingCandida orthopsilosisCandida parapsilosiscandidemiahigh mortality rateIran

Identifiers

PMID32509592
PMCPMC7253641
OpenAlexW3026989357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.